top of page
Search

Creatine Benefits After 40: What the Research Actually Shows About Muscle, Bone and Menopause

ginofallen
Sep 10
4 min read

A middle-aged woman in deadlift position with barbell in gym

For most of its history, creatine has been marketed almost exclusively to young men in gyms. That framing has quietly become out of date. Some of the most consistent clinical results now sit with an entirely different group: adults over 40, and particularly the benefits for post-menopausal women navigating the accelerated muscle and bone loss that comes with the hormonal shift of menopause.


This isn’t a trend claim. It’s a shift in where the research has been pointing for the better part of two decades — and it’s worth understanding in detail before deciding whether creatine belongs in your own protocol.


Why age changes the case for creatine

From your mid-30s onward, the body enters a slow, cumulative process of muscle loss known as sarcopenia — typically 3–8% of muscle mass per decade, accelerating further after 60. For women, menopause adds a second front: the drop in oestrogen is linked to faster loss of both muscle and bone density, independent of ageing alone[1].


Creatine monohydrate works by increasing the availability of phosphocreatine in muscle tissue, which supports the rapid regeneration of ATP — the energy currency your muscles use during resistance training and daily physical effort. More available energy at the cellular level means better capacity to train hard and recover, which is precisely the mechanism that matters once natural muscle-building hormones decline.


What the clinical data shows to muscle and strength in over 40s

A comprehensive review in the journal Nutrients lays out the dosing evidence for women specifically, rather than assuming male study results transfer directly[2]:

Population

Protocol

Result

Older / post-menopausal women, short-term

0.3 g/kg/day (≈17–20 g/day) for 5–7 days

Short-term improvements in fat-free mass, strength and functional performance

Older / post-menopausal women, chronic use

5 g/day for 12 weeks, or ~7 g/day for 52 weeks, + resistance training

Greater gains in muscle accretion, strength and physical function vs. training alone

Older / post-menopausal women, low dose, no training

1 g/day for 52 weeks, then 3 g/day for 52 weeks

No effect on fat-free mass, bone density, strength, falls or fractures

The pattern across the data is consistent: creatine’s benefit is contingent on resistance training, and on an adequate dose. A large 2025 review of older adults found that ≥3 g/day combined with resistance training increased whole-body lean mass by roughly 1.2 kg more than training alone, and that hand-grip strength improved significantly (SMD 0.23, 95% CI 0.01–0.45, p = 0.04)[3].


One detail worth noting for anyone deciding how to start: lower-body strength gains were only statistically significant in trials that included a loading phase (SMD 0.29, p = 0.02) — without loading, the same meta-analysis found no significant lower-body effect[4]. This doesn’t mean loading is mandatory — daily 3–5 g dosing reaches the same saturation point, just more slowly — but it is a genuine trade-off worth knowing rather than glossing over.


The bone density question

Bone health data is more mixed, and it deserves an honest treatment rather than a marketing gloss.


In one trial, postmenopausal women taking 0.1 g/kg/day during a year of resistance training saw femoral-neck bone mineral density decline by 1.2%, compared with a 3.9% decline in the placebo group — a meaningful relative difference, though both groups still lost density[5]. A separate two-year trial using a higher dose alongside structured resistance and walking programs found improvements in bone geometry. However, another well-powered two-year randomised trial using a lower 3 g/day dose found no significant bone-density benefit at all.


The honest summary: creatine appears to support bone health at meaningful doses when paired with structured resistance training, but it is not a stand-alone bone-density treatment, and the evidence is not yet uniform. Anyone with osteoporosis or a bone-health condition should treat this as a discussion for their physician, not a headline claim.


What this means in practice

  1. Dose matters. Most of the meaningful outcomes above used 5 g/day or higher, sustained over 12 weeks or longer — not token amounts.

  2. Resistance training is the other half of the equation. Creatine amplifies what training already does; it does not replace it.

  3. Consistency beats loading. A loading phase (typically 20 g/day for 5–7 days) reaches saturation faster, but daily 3–5 g dosing gets you to the same place within about four weeks.

  4. Purity is non-negotiable at this dose. At 5 g or more per day, sustained over months or years, the quality and contaminant profile of the creatine you’re taking matters more than it would for occasional use. See our companion article, “What’s Actually in Your Creatine?”, for a full breakdown of independent testing on commercial creatine products.


bne nutrients uses Pürest Creatine™, a single-ingredient creatine monohydrate manufactured by NNB Nutrition using a proprietary low-temperature synthesis process specifically designed to minimise the contaminants — dicyandiamide (DCD) and dihydrotriazine (DHT) — found in lower-grade creatine. Every production lot is third-party tested using the USP method, with a batch-level certificate of analysis. No flavours, no fillers, no proprietary blend — just creatine monohydrate, dosed the way the research above describes.


This isn’t a claim that creatine is a cure for menopause-related muscle or bone loss, or that results are guaranteed. It’s a summary of what a growing, credible body of research says about a well-studied compound — so you can decide, with your own data and your own doctor, whether it belongs in your protocol.

This article is for general educational purposes and does not constitute medical advice. Consult your healthcare provider before starting any new supplement, particularly if you have an existing bone, kidney or cardiovascular condition.


Sources


[1]Creatine Supplementation in Women’s Health: A Lifespan Perspective, PMC — https://pmc.ncbi.nlm.nih.gov/articles/PMC7998865/

[2]Journal of the International Society of Sports Nutrition, 2025 — https://www.tandfonline.com/doi/full/10.1080/15502783.2025.2534130

[3]Creatine monohydrate supplementation for older adults and clinical populations, PMC — https://pmc.ncbi.nlm.nih.gov/articles/PMC12272710/

[4]Creatine monohydrate supplementation for older adults and clinical populations, PMC — https://pmc.ncbi.nlm.nih.gov/articles/PMC12272710/

[5]Creatine monohydrate supplementation for older adults and clinical populations, PMC — https://pmc.ncbi.nlm.nih.gov/articles/PMC12272710/

 
 
 

Comments

bottom of page